DEA Slaps Seven Deadly Opioids into Schedule I Lockdown
Published Date: 10/15/2025
Rule
Summary
Starting October 15, 2025, the DEA is temporarily putting seven powerful new opioids into Schedule I, meaning they’re considered very dangerous with no accepted medical use. This affects anyone who makes, sells, studies, or even possesses these drugs, who will now face strict rules and penalties. The temporary ban lasts two years, giving the government time to keep people safe while deciding what’s next.
Analyzed Economic Effects
6 provisions identified: 0 benefits, 6 costs, 0 mixed.
Seven Nitazenes Placed in Schedule I
Starting October 15, 2025, DEA temporarily places seven benzimidazole-opioids (ethyleneoxynitazene; methylenedioxynitazene; 5-methyl etodesnitazene; N-desethyl etonitazene; N-desethyl protonitazene; N,N-dimethylamino etonitazene; and N-pyrrolidino isotonitazene) in Schedule I through October 15, 2027 (with a possible one-year extension). Schedule I means these substances are treated as having high potential for abuse and no accepted medical use and are subject to Schedule I controls and sanctions.
Unauthorized Possession and Retail Sales Outlawed
Possessing any quantity of these seven substances in a manner not authorized by the Controlled Substances Act on or after October 15, 2025 is unlawful and may subject you to administrative, civil, and criminal sanctions; retail sales of Schedule I controlled substances to the general public are not allowed under the CSA.
Registration Required to Handle These Drugs
As of October 15, 2025, anyone who handles (manufactures, distributes, imports/exports, researches, analyzes, or possesses) these seven substances must be registered with DEA under 21 U.S.C. 822, 823, 957, and 958 and 21 CFR parts 1301 and 1312. Persons currently handling these substances who are not registered must submit an application and may not continue to handle them unless DEA approves the registration.
Surrender or Dispose Stocks If Not Registered
If you possess any of these seven substances and do not want or cannot obtain a Schedule I registration, you must surrender all currently held quantities; you may not continue to lawfully hold them after October 15, 2025. The temporary order requires disposal or surrender of stocks by persons who will not be registered.
Immediate Security, Labeling, Inventory, and Reporting Rules
Beginning October 15, 2025, registrants handling these substances must meet Schedule I security requirements (21 CFR 1301.71-1301.93), labeling and packaging rules, take required inventories (initial inventory and biennial thereafter), maintain records, and submit reports and order forms as specified in 21 U.S.C. and 21 CFR parts (with current registrants given 30 calendar days from October 15, 2025 to comply with labeling, inventory, and recordkeeping requirements).
Manufacture Limited to DEA-Registered Quota Holders
Only DEA-registered manufacturers may lawfully manufacture these seven substances, and manufacturing is limited to quotas assigned under 21 U.S.C. 826 and 21 CFR part 1303, effective October 15, 2025. Manufacturers must comply with quota, order form, import/export, and reporting requirements.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-10253 — Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
Starting May 22, 2026, the DEA is putting 2-fluorodeschloroketamine (2-FDCK) into Schedule I, meaning it’s now treated like the most dangerous drugs. This affects anyone who makes, sells, or uses it, adding strict rules and serious penalties. The temporary ban lasts two years, giving the government time to decide if it should stay permanent.
2026-10090 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) reviewed and decided on applications for special chemical mixtures that don’t fall under strict drug rules, covering requests from July 2025 to March 2026. Some mixtures got approved, others denied, and a few listings were fixed from earlier notices. If you’re involved with these chemicals, you’ve got until July 20, 2026, to share your thoughts—no fees or big costs involved, just your voice!
2026-09566 — Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Starting May 13, 2026, the DEA officially puts CUMYL-PEGACLONE—a chemical that can be risky—into Schedule I, the strictest drug category. This means anyone making, selling, or using it now faces tough rules and penalties. This move helps the U.S. follow international drug laws and keeps communities safer without any new fees or costs.
2026-08587 — Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.
ANI Pharmaceuticals wants to import certain controlled drugs like Levorphanol and Tapentadol. People who make or use these drugs can share their thoughts or ask for a hearing by June 3, 2026. This move could affect drug availability and regulation, so keep an eye on the deadline to have your say!
2026-08588 — Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Patheon API Inc. wants to make large amounts of special research drugs like dimethyltryptamine and psilocybin. This affects researchers and companies involved in clinical trials, with a chance to comment or ask for a hearing by July 6, 2026. No money changes are mentioned, but this move could speed up important medical studies.
Previous / Next Documents
Previous: 2025-19537 — Fisheries of the Exclusive Economic Zone Off Alaska; Atka Mackerel in the Bering Sea Subarea and Eastern Aleutian District of the Bering Sea and Aleutian Islands Management Area
Starting October 9, 2025, fishing boats in the Bering Sea and Eastern Aleutian District have to stop catching Atka mackerel because they’ve hit their 2025 limit. This temporary closure helps protect the fish and keeps the fishing fair for everyone involved. The rule lasts until the end of 2025 and mainly affects trawl fishing vessels in the area.
Next: 2025-19554 — Airworthiness Directives; Airbus Helicopters
If you own or fly an Airbus H160-B helicopter, listen up! The FAA found some broken parts in the main gearbox supports and now requires regular checks for cracks and fixes if needed. Starting October 30, 2025, you can’t install certain parts unless they meet new safety rules—so get ready to inspect, fix, and keep flying safe without breaking the bank.